Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface ; volume:13 ; number:1 ; day:15 ; month:2 ; year:2023 ; pages:1-2 ; date:12.2023
Scientific reports ; 13, Heft 1 (15.2.2023), 1-2, 12.2023

Creator: Pirolli, Davide
Righino, Benedetta
Camponeschi, Chiara
Ria, Francesco
Sante, Gabriele Di
Rosa, Maria Cristina De

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-023-29766-8

URN: urn:nbn:de:101:1-2023041921123345286159

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pirolli, Davide
Righino, Benedetta
Camponeschi, Chiara
Ria, Francesco
Sante, Gabriele Di
Rosa, Maria Cristina De
SpringerLink (Online service)

Other Objects (12)

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level

Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Substitution of T403R allows efficient utilization of human ACE2 by Spike proteins of bat coronaviruses

SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level

Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Substitution of T403R allows efficient utilization of human ACE2 by Spike proteins of bat coronaviruses

SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level

Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Substitution of T403R allows efficient utilization of human ACE2 by Spike proteins of bat coronaviruses

SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Publisher Correction: Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level

Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Substitution of T403R allows efficient utilization of human ACE2 by Spike proteins of bat coronaviruses

SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level

Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Substitution of T403R allows efficient utilization of human ACE2 by Spike proteins of bat coronaviruses

SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Spike residue 403 affects binding of coronavirus spikes to human ACE2

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level

Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis

Substitution of T403R allows efficient utilization of human ACE2 by Spike proteins of bat coronaviruses

SARS‐CoV ‐2 spike protein enhances MAP4K3/GLK ‐induced ACE2 stability in COVID ‐19

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication

Related objects

Reset password